Basic Information
LncRNA/CircRNA Name | BLACAT1 |
Synonyms | NA |
Region | GRCh38_1:205434886-205437879 |
Ensemble | ENSG00000281406 |
Refseq | NR_103783 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | RT-PCR, Western blotting, Luciferase Assays, RIP |
Sample | Prostate cancer tumor tissue,cell lines( PC3 and DU145,RWPE-1) |
Expression Pattern | down-regulated |
Function Description | In patient samples and prostate cancer cell lines, BLACAT1 was down-regulated .The BALCAT1 promoter was methylated in prostate cancer tissue and found to interact with miR-361 via luciferase assays. |
Pubmed ID | 31957820 |
Year | 2020 |
Title | Long Non-Coding RNA BLACAT1 Inhibits Prostate Cancer Cell Proliferation Through Sponging miR-361 |
External Links
Links for BLACAT1 | GenBank HGNC NONCODE |
Links for prostate cancer | OMIM COSMIC |